| VERICEL CORP. |
| USA |
| Gesundheit |
| US92346J1088 / A12FU4 |
| ATQP (Frankfurt) / VCEL (NASDAQ) |
| FRA:ATQP, ETR:ATQP, ATQP:GR, NASDAQ:VCEL |
| - |
| https://www.vcel.com/ |
|
Vericel Corporation is a biopharmaceutical company..
>Volltext.. |
| 1629.95 Mio. EUR |
| 1616.95 Mio. EUR |
| 216.32 Mio. EUR |
| 8.26 Mio. EUR |
| 6.17 Mio. EUR |
| 0.13 EUR |
| 88.17 Mio. EUR |
| 69.93 Mio. EUR |
| 41.02 Mio. EUR |
| 2.84 |
| 5.59% |
| 719.04% |
| - |
| - |
| - |
| - |
| VERICEL, AASTROM |
| 06.11.25 |